Yaz, Yasmin and other newer birth control pills will soon be bearing warning labels that detail the potential risk of blood clot risks, the U.S. Food and Drug Administration (FDA) announced on Tuesday ...
No rest for the Food and Drug Administration (FDA) this week. In addition to considering broadened access to the emergency contraceptive Plan B, an FDA panel decided on Thursday to update labeling on ...
Watson, Bayer in patent lawsuit over Yaz Yaz had U.S. sales of $173 mln for year ended Sept. 30 Nov 29 (Reuters) - Watson Pharmaceuticals Inc said it received U.S. regulatory approval for a generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback